Warner Chilcott Statement Regarding Market Speculation
May 10, 2013 14:45 ET
|
Warner Chilcott
DUBLIN, Ireland, May 10, 2013 (GLOBE NEWSWIRE) -- Further to media speculation, the Board of Warner Chilcott plc (Nasdaq:WCRX) confirmed today that the Company is engaged in preliminary discussions...
Warner Chilcott Reports Operating Results for the Quarter Ended March 31, 2013
May 10, 2013 07:30 ET
|
Warner Chilcott
DUBLIN, Ireland, May 10, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced its results for the quarter ended March 31, 2013.
Total revenue in the quarter ended March 31,...
Warner Chilcott Announces FDA Approval of New Oral Contraceptive
May 09, 2013 08:00 ET
|
Warner Chilcott
DUBLIN, Ireland, May 9, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that the United States Food and Drug Administration (FDA) has approved a new oral contraceptive,...
Warner Chilcott Declares Semi-Annual Cash Dividend of $0.25 Per Share
May 07, 2013 16:30 ET
|
Warner Chilcott
DUBLIN, Ireland, May 7, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Board of Directors declared a semi-annual cash dividend in the amount of $0.25 per share,...
Warner Chilcott Announces Changes to Board of Directors
May 02, 2013 16:15 ET
|
Warner Chilcott
DUBLIN, Ireland, May 2, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Board of Directors has voted unanimously to appoint Paul Herendeen, the Company's Executive...
Warner Chilcott Announces Earnings Release Date and Conference Call for First Quarter 2013 Financial Results
May 01, 2013 16:15 ET
|
Warner Chilcott
DUBLIN, Ireland, May 1, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that it will issue its first quarter 2013 financial results prior to the market opening on Friday,...
Warner Chilcott Announces FDA Approval of New Oral Contraceptive
April 22, 2013 08:00 ET
|
Warner Chilcott
DUBLIN, Ireland, April 22, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that the United States Food and Drug Administration (FDA) has approved MINASTRINTM 24 FE...
Warner Chilcott Announces FDA Approval of DORYX(R) Delayed-Release 200 mg Tablets
April 12, 2013 08:00 ET
|
Warner Chilcott
DUBLIN, Ireland, April 12, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that the United States Food and Drug Administration (FDA) has approved a 200 mg strength of...
Warner Chilcott to Present at the 2013 Goldman Sachs Leveraged Finance Healthcare Conference
March 04, 2013 17:00 ET
|
Warner Chilcott
DUBLIN, Ireland, March 4, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Executive Vice President and Chief Financial Officer, Paul Herendeen, is scheduled to...
Warner Chilcott to Present at the 2013 RBC Capital Markets Healthcare Conference
February 22, 2013 16:20 ET
|
Warner Chilcott
DUBLIN, Ireland, Feb. 22, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Executive Vice President and Chief Financial Officer, Paul Herendeen, is scheduled to...